Back to News
Market Impact: 0.05
PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases
Source: GlobeNewswire
Healthcare & Biotech
A virtual event featuring Jonathan M. Hernandez, M.D., an investigator in the Surgical Oncology Program at NCI/CCR, is scheduled for October 15, 2026, at 8 a.m. ET. The announcement provides no additional event details or market-relevant information.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Why is Telix Pharmaceuticals stock rallying today?
- Why is Natera stock sliding today?
- ArriVent BioPharma Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ArriVent BioPharma (AVBP)
- Xenon Pharmaceuticals stock hits 52-week low at 36.06 USD
- McKesson and CD&R agree to acquire Option Care Health for $5.8 billion
- LQDA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Liquidia Corporation